SoylentNews

fliptop [soylentnews.org] writes:

Regeneron has agreed to buy 23andMe, the once buzzy genetic testing company, out of bankruptcy for $256 million under a court-supervised sale process [cbsnews.com]:

23andMe declared bankruptcy in March [cbsnews.com] and announced it would seek a buyer, while also saying that co-founder and CEO Anne Wojcicki would resign.

Under the proposed agreement with Regeneron, the Tarrytown, New York, drugmaker will acquire 23andMe's assets, including its personal genome service and total health and research services. Regeneron said Monday that it will abide by 23andMe's privacy policies and applicable law to protect customer data.

Data privacy experts had raised concerns about 23andMe's [cbsnews.com] storehouse of data for about 15 million customers, including their DNA.

23andMe's consumer-genome services will continue interrupted, the purchaser said. Regeneron will not acquire 23andMe's Lemonaid Health telehealth business.

Also at ZeroHedge [zerohedge.com].

Previously: 23andMe Reportedly Faces Bankruptcy — What Will Happen to Everyone’s DNA Samples? [soylentnews.org]

Original Submission